Current risk assessment and management paradigms: Snapshots in the life of the pain specialist

Pain Medicine

Volumn 10, Issue SUPPL. 2, 2009, Pages

  Passik, Steven D ^a,b   Squire, Pamela ^c,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d LIONS GATE HOSPITAL   (Canada)

Author keywords

Chronic Pain; Opioids; Patient Selection; Risk Assessment; Risk Management

Indexed keywords

OPIATE;

CASE STUDY; CHRONIC PAIN; CLINICAL PRACTICE; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; FAMILY HISTORY; HIGH RISK PATIENT; HUMAN; IATROGENIC DISEASE; INTERVIEW; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MEDICOLEGAL ASPECT; PATIENT ASSESSMENT; PATIENT MONITORING; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PSEUDOADDICTION; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

ANALGESICS, OPIOID; BEHAVIOR; CHRONIC DISEASE; DRUG PRESCRIPTIONS; GUIDELINES AS TOPIC; HUMANS; OPIOID-RELATED DISORDERS; PAIN; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT; SPECIALTIES, MEDICAL;

EID: 68449094351     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00670.x     Document Type: Review

References (63)

1. Groopman J. How Doctors Think. Boston, MA: Houghton Mifflin; 2007.
2. American Pain Foundation. 2006 Annual Report. Available at: http://www.painfoundation.org/About/2006annualReport.pdf (accessed September 12, 2008).
3. Woolf CJ. Somatic pain - Pathogenesis and prevention. Br J Anaesth 1995;75(2):169-76.
4. American Board of Pain Medicine. Frequently asked questions. Available at: http://www.abpm.org/faq/index.html (accessed November 21, 2008).
5. Breuer B, Pappagallo M, Tai JY, Portenoy RK. U.S. board-certified pain physician practices: Uniformity and census data of their locations. J Pain 2007;8(3):244-50.
6. Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22(9):1859-65.
7. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146(2):116-27.
8. Brown RT, Zuelsdorff M, Fleming M. Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag 2006;2(3):137-46.
9. Nwokeji ED, Rascati KL, Brown CM, Eisenberg A. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain. Clin Ther 2007;29(suppl):2589-602.
10. Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003;38(3):435-45.
11. Haddox D, Joranson D, Angarola RT, et al. The use of opioids for the treatment of chronic pain [consensus statement]. Clin J Pain 1997;13:6-8.
12. Savage SR, Joranson DE, Covington EC, et al. Definitions related to the medical use of opioids: Evolution towards universal agreement. J Pain Symptom Manage 2003;26(1):655-67.
13. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147(7):478-91.
14. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007;132(3):237-51.
15. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16(2):137-62.
16. Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008;11(2 suppl):S5-62.
17. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002;18(4 suppl):S28-38.
18. Chou R, Fanciullo GJ, Fine PG. Opioid treatment guidelines. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-30.
19. National Guidelines Clearinghouse. Available at: http://www.guideline.gov (accessed November 21, 2008).
20. Federation of State Medical Boards of the United States I. Model policy for the use of controlled substances for the treatment of pain. 2004. Available at: http://www.fsmb.org/pdf/ 2004_grpol_Controlled_Substances.pdf (accessed October 15, 2008).
21. Ohio Automated Rx Reporting System. Ohio Automated Rx Reporting System (OARRS) Handbook. Available at: http://www.ohiopmp.gov/Documents/ OH_PMP_Handbook-FINAL.pdf (accessed August 5, 2008).
22. Katz N. The Patient EDU Supplement: Patient level opioid risk management. Inflexxion, Inc., Needham, MA; 2007.
23. US Department of Justice Drug Enforcement Administration. Office of Diversion Control. State Prescription Drug Monitoring Programs. Available at: http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm# (accessed August 5, 2008).
24. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain 2007;130(1-2):144-56.
25. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 2008;9(4):360-72.
26. Saffier K, Colombo C, Brown D, Mundt MP, Fleming MF. Addiction Severity Index in a chronic pain sample receiving opioid therapy. J Subst Abuse Treat 2007;33(3):303-11.
27. Coambs RB, Jarry JL. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain in general medical practice. Pain Res Manage 1996;1(3):155-62.
28. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med 2005;6(6):432-42.
29. Dowling LS, Gatchel RJ, Adams LL, Stowell AW, Bernstein D. An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain. J Opioid Manag 2007;3(5):257-66.
30. Wu SM, Compton P, Bolus R, et al. The addiction behaviors checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage 2006;32(4):342-51.
31. Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: A brief questionnaire to assess misuse. J Subst Abuse Treat 2008;35(4):380-6.
32. Skinner HA. The drug abuse screening test. Addict Behav 1982;7(4):363-71.
33. Wallace LS, Keenum AJ, Roskos SE. Comprehensibility and readability of patient self-administered opioid assessment screening tools. J Opioid Manag 2007;3(6):338-44.
34. Wasan AD, Butler SF, Budman SH, etal. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 2007;23(4):307-15.
35. Edlund MJ, Sullivan M, Steffick D, Harris KM, Wells KB. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med 2007;8(8):647-56.
36. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129(3):355-62.
37. Wilsey BL, Fishman SM, Tsodikov A, et al. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med 2008;9(8):1107-17.
38. Manchikanti L, Giordano J, Boswell MV, et al. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 2007;3(2):89-100.
39. Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend 2008;92(1-3):267-76.
40. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006;6:46.
41. Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28(3):250-8.
42. Passik SD, Kirsh KL. Opioid therapy in patients with a history of substance abuse. CNS Drugs 2004;18(1):13-25.
43. Dews TE, Mekhail N. Safe use of opioids in chronic noncancer pain. Cleve Clin J Med 2004;71(11):897-904.
44. Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D. Misuse of and dependence on opioids: Study of chronic pain patients. Can Fam Physician 2006;52(9):1081-7.
45. Backonja MM, Argoff C. Neuropathic pain: Definition and implications for research and therapy 2005. J Neuropathic Pain Symptom Palliation 2005;1:11-17.
46. Fishman SM, Kreis PG. The opioid contract. Clin J Pain 2002;18(4 suppl):S70-5.
47. Passik SD, Kirsh KL. Managing pain in patients with aberrant drug-taking behaviors. J Support Oncol 2005;3(1):83-6.
48. Hariharan J, Lamb GC, Neuner JM. Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. Soc Gen Intern Med 2007;22:485-90.
49. Roskos SE, Keenum AJ, Newman LM, Wallace LS. Literacy demands and formatting characteristics of opioid contracts in chronic nonmalignant pain management. J Pain 2007;8(10):753-8.
50. Wallace LS, Keenum AJ, Roskos SE, McDaniel KS. Development and validation of a low-literacy opioid contract. J Pain 2007;8(10):759-66.
51. Compton P. The role of urine toxicology in chronic opioid analgesic therapy. Pain Manag Nurs 2007;8(4):166-72.
52. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003;97(4):1097-102; Table of Contents.
53. Manchikanti L, Manchukonda R, Pampati V, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006;9(2):123-9.
54. Manchikanti L, Manchukonda R, Damron KS, et al. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006;9(1):57-60.
55. Tait RC, Pollard CA, Margolis RB, Duckro PN, Krause SJ. The Pain Disability Index: Psychometric and validity data. Arch Phys Med Rehabil 1987;68(7):438-41.
56. Harris CA, D'Eon JL. Psychometric properties of the Beck Depression Inventory-Second edition (BDI-II) in individuals with chronic pain. Pain 2008;137(3):609-22.
57. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006;166(10):1092-7.
58. Zimmermann P, Wittchen HU, Hofler M, et al. Primary anxiety disorders and the development of subsequent alcohol use disorders: A 4-year community study of adolescents and young adults. Psychol Med 2003;33(7):1211-22.
59. Kirsh KL, Jass C, Bennett DS, Hagen JE, Passik SD. Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 2007;5(3):219-26.
60. Passik SD, Kirsh KL. The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol 2008;16(5):400-4.
61. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 2007;8(7):573-84.
62. Belgrade MJ. Opioids for chronic nonmalignant pain. Choosing suitable candidates for long-term therapy. Postgrad Med 1999;106(6):115-16, 119-24.
63. Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998;14(4):245-58.